Erik Renström is Vice-Chancellor of Lund University, Sweden, where he oversees university activities and leads the University Board. He is professor of Experimental Endocrinology and leading researcher in hormone secretion and translational diabetes research. He graduated from the Institute of Medicine at the University of Gothenburg, Sweden in 1990 and has since held several positions at Lund University and the Swedish Research Council.
Professor Renström’s research focuses on diabetes, particularly the insulin-producing beta cells in the pancreas. His research group primarily investigates beta cells by electrophysiology, live imaging and super-resolution microscopy. The group has a particular interest in genetic or environmental factors that accelerate ageing and reactions in the beta cell that increase the risk of diabetes. He has conducted diabetes research in Lund and Gothenburg, spent time completing postdoctoral studies in the UK and worked at Novo Nordisk A/S. He has previously served as Vice Co-ordinator of the Linnaeus grant for diabetes research at Lund University, as co-ordinator for EXODIAB, as a Board Member for Clinical Research Center, Malmö and Department of Clinical Sciences, Malmö and as Dean of the Faculty of Medicine at Lund University.
Professor Renström has published over 70 articles in peer-reviewed journals. He has participated as an invited speaker at numerous conferences, including the American Diabetes Association’s (ADA) Scientific Sessions, and has been the recipient of the Paul Langerhans Award and awards bestowed by Lund University and the Swedish Research Council.